机译:误诊对中国非小细胞肺癌患者致病性系BRCA1 / 2突变的患病率和临床意义
department of Medical Oncology National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital Chinese Academy of Medical Sciences and Peking Union Medical College Beijing 100021 China;
Department of Pulmonary Medicine Second Affiliated Hospital of Fujian Medical University Quanzhou 362100 China;
Department of Respiratory Medicine West China Hospital Sichuan University Chengdu 610041 China;
Department of Respiratory Medicine Daping Hospital Chongqing 400042 China;
Department of Respiratory Medicine Xinqiao Hospital Army Medical University Chongqing 400037 China;
Department of Medical Oncology Tianjin Medical University Cancer Institute and Hospital National Clinical Research Center for Cancer Key Laboratory of Cancer Prevention and Therapy Tianjin Tianjin''s Clinical Research Center for Cancer Tianjin 300060 China;
Department of Thoracic Oncology Tianjin Medical University General Hospital Tianjin 300052 China;
Department of Medical Oncology Hunan Cancer Hospital Changsha 410006 China;
Department of Pathology Xiangya Hospital Central South University Changsha 410008 China;
Department of Respiratory Medicine Xiangya Hospital Central South University Changsha 410008 China;
Burning Rock Biotech Guangzhou 510300 China;
Burning Rock Biotech Guangzhou 510300 China;
Burning Rock Biotech Guangzhou 510300 China;
Burning Rock Biotech Guangzhou 510300 China;
Burning Rock Biotech Guangzhou 510300 China;
Burning Rock Biotech Guangzhou 510300 China;
Department of Oncology Tongji Hospital of Tongji Medical College Huazhong University of Science and Technology Wuhan 430022 China;
Department of Respiratory Medicine Xiangya Hospital Central South University Changsha 410008 China;